Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 33.950
- -0.220-0.64%
Close Dec 13 16:00 ET
- 34.050
- +0.100+0.29%
Post 19:57 ET
69.27BMarket Cap22.07P/E (TTM)
34.080High33.754Low3.39MVolume34.020Open34.170Pre Close115.10MTurnover0.17%Turnover Ratio11.17P/E (Static)2.04BShares44.84752wk High3.90P/B67.07BFloat Cap32.82552wk Low1.60Dividend TTM1.98BShs Float44.847Historical High4.71%Div YieldTTM0.96%Amplitude6.373Historical Low33.938Avg Price1Lot Size
About GlaxoSmithKline Company
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Company Profile
SymbolGSK
Company NameGlaxoSmithKline
Listing DateDec 27, 2000
CEOMs. Emma N. Walmsley
MarketNYSE
Employees70212
Securities TypeDR
ADS Ratio1.0 : 2.0
Fiscal Year Ends12-31
Address79 New Oxford Street
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeWC1A 1DG
Phone44-20-8047-5000
Websitehttp://www.gsk.com
Company Executives
- Name
- Position
- Salary
- Emma N. Waley
- Executive Director,Chief Executive Officer
- 12.72M
- Julie Brown
- Executive Director,Chief Financial Officer
- 4.83M
- Sir Jonathan Richard Symonds CBE
- Non-Executive Director,Chairman
- 765.00K
- Wendy Becker
- Non-Executive Director
- 32.00K
- Dr. Jeannie Lee
- Non-Executive Director
- --
- Dr. Harry C Dietz
- Non-Executive Director
- 264.00K
- Dr. Vishal Sikka
- Non-Executive Director
- 147.00K
- Dr. Jesse Goodman, M.D.,M.P.H.
- Non-Executive Director
- 221.00K
- Dr. Anne Beal
- Non-Executive Director
- 223.00K
- Elizabeth McKee Anderson
- Non-Executive Director
- 163.00K
- Dr. Hal V Barron
- Non-Executive Director
- 455.00K
- Charles A. Bancroft
- Non-Executive Director,Senior Independent Director
- 323.00K
- . Victoria Anne Whyte
- Company Secretary
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
